Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 628535
                    [Title] => Roche drug approved as first-line blood cancer maintenance treatment
                    [Summary] => 
BASEL, Switzerland — Roche announced recently that the European Commission has approved the use of rituximab as a maintenance treatment for people suffering from follicular lymphoma, a common type of blood cancer, who have responded to initial induction therapy.
                    [DatePublished] => 2010-11-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

PROFESSOR GILLES SALLES

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 628535
                    [Title] => Roche drug approved as first-line blood cancer maintenance treatment
                    [Summary] => 
BASEL, Switzerland — Roche announced recently that the European Commission has approved the use of rituximab as a maintenance treatment for people suffering from follicular lymphoma, a common type of blood cancer, who have responded to initial induction therapy.
                    [DatePublished] => 2010-11-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Roche drug approved as first-line blood cancer maintenance treatment

November 11, 2010 - 12:00am

BASEL, Switzerland — Roche announced recently that the European Commission has approved the use of rituximab as a maintenance treatment for people suffering from follicular lymphoma, a common type of blood...

Science and Environment